Diclofenac-SOLOpharm

Application area

  • Inhibition of miosis during cataract surgery (the medicine does not have mydriatic properties and does not replace the standard ones);
  • Treatment and prevention of inflammatory processes after surgery on the eyeball;
  • Prevention of cystic macular oedema after cataract surgery;
  • Treatment of non-infectious conjunctivitis;
  • Treatment and prevention of post-traumatic inflammatory process in penetrating and non-penetrating eyeball injuries (as an adjunct to local antibacterial therapy)

Application area

Non-steroidal anti-inflammatory drug

Market authorization in the following countries

Kyrgyzstan

Tajikistan

Back to catalog